Our results show that hAAT is indeed able to inhibit ADAM-17, confirming the original report by Bergin et al. (2010), elucidating one possible mechanism of action for hAAT in the context of CMT1A. The gene discussed is ADAM17; the disease is Charcot-Marie-Tooth disease type 1A.